{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:29:41Z","timestamp":1773898181686,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.lfs.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T20:50:17Z","timestamp":1444769417000},"page":"193-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Chemopreventive effect of leflunomide against Ehrlich's solid tumor grown in mice: Effect on EGF and EGFR expression and tumor proliferation"],"prefix":"10.1016","volume":"141","author":[{"given":"Hoda I.","family":"Bahr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.","family":"Toraih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala M.F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.I.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan A.","family":"Zaitone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085891","article-title":"Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1\u20137)","volume":"9","author":"Abd-Alhaseeb","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jss.2013.05.089","article-title":"Leflunomide suppresses growth in human medullary thyroid cancer cells","volume":"185","author":"Alhefdhi","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0015","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1172\/JCI118734","article-title":"Inhibition of interlukin-8 reduces tumorigenesis of human nonsmall cell lung cancer in SCID mice","volume":"97","author":"Arenberg","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2015.10.003_bb0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.184.3.981","article-title":"Interferon-g inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases","volume":"184","author":"Arenberg","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2015.10.003_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1083\/jcb.126.1.247","article-title":"Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells","volume":"126","author":"Aylon","year":"1994","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0030","first-page":"169","article-title":"The anti-tumor effect of bee honey in Ehrlich ascite. Tumor model of mice is coincided with stimulation of the immune cells","volume":"15","author":"Attia","year":"2008","journal-title":"Egypt. J. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2015.10.003_bb0035","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/ndt\/gfr416","article-title":"Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient","volume":"26","author":"Basu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0040","first-page":"278","article-title":"Effect of leflunomide (avar a) drug on the lung of adult male albino rats: a histological and immunohistochemical study","volume":"31","author":"Bayomy","year":"2008","journal-title":"Egy. J. Histol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0045","first-page":"1850","article-title":"Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival","volume":"7","author":"Brabender","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0050","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1152\/ajpcell.00084.2014","article-title":"Type-2 pericytes participate in normal and tumoral angiogenesis","volume":"307","author":"Birbrair","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0055","first-page":"102","article-title":"Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis","volume":"67","author":"Bilasy","year":"2014","journal-title":"Pharmacol. Rep. 2015"},{"issue":"10","key":"10.1016\/j.lfs.2015.10.003_bb0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/pros.21319","article-title":"Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers","volume":"71","author":"Blann","year":"2011","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2011.08.025","article-title":"Leflunomide in dermatology","volume":"66","author":"Boyd","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/624815","article-title":"The Ehrlich tumor induces pain-like behavior in mice: a novel model of cancer pain for pathophysiological studies and pharmacological screening","volume":"2013","author":"Calixto-Campos","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.lfs.2015.10.003_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other dis eases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1013849123736","article-title":"The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines","volume":"19","author":"Cooper","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0085","first-page":"671","article-title":"Involvement of endothelial PECAM-1\/CD31 in angiogenesis","volume":"151","author":"DeLisser","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/1078-0432.CCR-11-1049","article-title":"Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells","volume":"18","author":"Dietrich","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.10.003_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006436624862","article-title":"Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs","volume":"50","author":"Dunn","year":"2000","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0100","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5858\/2001-125-0872-CIAOPA","article-title":"Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium","volume":"125","author":"Elhafey","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lfs.2015.10.003_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard.62.5.440","article-title":"Active leflunomide metabolite inhibits interleukin 1, tumour necrosis factor, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures","volume":"62","author":"Elkayam","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2015.10.003_bb0110","first-page":"65","article-title":"Experimentelle karzinom-studien an m\u00e4usen","volume":"1","author":"Ehrlich","year":"1906","journal-title":"Arch. Insect. Exp. Ther."},{"key":"10.1016\/j.lfs.2015.10.003_bb0115","first-page":"2315","article-title":"Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification","volume":"9","author":"Ekstrand","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2015.10.003_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1005800114912","article-title":"Signal transduction pathways and their relevance in human astrocytomas","volume":"35","author":"Feldkamp","year":"1997","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clim.1999.4777","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.reprotox.2007.05.006","article-title":"Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor leflunomide in mice","volume":"24","author":"Fukushima","year":"2007","journal-title":"Reprod. Toxicol."},{"issue":"12","key":"10.1016\/j.lfs.2015.10.003_bb0135","first-page":"2485","article-title":"Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer","volume":"3","author":"Giatromanolaki","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0140","first-page":"79","article-title":"In vitro studies for evaluation the antitumoral and immunomodulator effect of EGCG on Ehrlich ascites","volume":"5","author":"Gherman","year":"2012","journal-title":"Arch. Zootech."},{"key":"10.1016\/j.lfs.2015.10.003_bb0145","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/ard.2008.096743","article-title":"Inhibition of TNF and IL-17 production by leflunomide involves the JAK\/STAT pathway","volume":"68","author":"Gonz\u00e1lez-Alvaro","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.lfs.2015.10.003_bb0150","first-page":"580","article-title":"Effects of leflunomide on the proliferation and apoptosis of human keratinocytes","volume":"36","author":"Guo","year":"2003","journal-title":"Chi. J. Dermatol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0155","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/annonc\/mdg284","article-title":"Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?","volume":"14","author":"Graziano","year":"2003","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulatory microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"Heneghan","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.lfs.2015.10.003_bb0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"38","key":"10.1016\/j.lfs.2015.10.003_bb0170","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.3748\/wjg.v18.i38.5360","article-title":"Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas","volume":"18","author":"Hosono","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.lfs.2015.10.003_bb0175","first-page":"2736","article-title":"Angiogenesis and prostate cancer: identification of a molecular progression switch","volume":"61","author":"Huss","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-8722-3-26","article-title":"Angiogenesis inhibitors in the treatment of prostate cancer","volume":"3","author":"Hwang","year":"2010","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02907807","article-title":"Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer","volume":"3","author":"Jablonska","year":"1997","journal-title":"Pathol. Oncol. Res."},{"issue":"8","key":"10.1016\/j.lfs.2015.10.003_bb0190","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0006-2952(98)00131-2","article-title":"Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria","volume":"56","author":"Jockel","year":"1998","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2015.10.003_bb0195","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","article-title":"Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Kaltwasser","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000093002","article-title":"Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF \u2014 an independent prognostic factor","volume":"70","author":"Kaminska","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.lfs.2015.10.003_bb0205","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrurol.2010.134","article-title":"Therapeutic targeting of the prostate cancer microenvironment","volume":"7","author":"Karlou","year":"2010","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0210","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1074\/jbc.M114.619783","article-title":"Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development","volume":"290","author":"Kim","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2015.10.003_bb0215","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2003.014738","article-title":"Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis","volume":"63","author":"Kraan","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2015.10.003_bb0220","series-title":"Robbins Basic Pathology: With STUDENT CONSULT online access","first-page":"1","article-title":"Cell injury and cell death and adaptations","author":"Kumar","year":"2007"},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.21475","article-title":"Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury","volume":"45","author":"Latchoumycandane","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0230","first-page":"1","article-title":"Metastatic cells can escape the proapoptotic effects of TNF-\u03b1 through increased autocrine IL-6\/STAT3 signaling","volume":"72","author":"Li","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0235","first-page":"753","article-title":"Expression of epidermal growth factor receptors in human brain tumors","volume":"44","author":"Libermann","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2005.12.009","article-title":"The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis","volume":"33","author":"Litinsky","year":"2006","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C (T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2015.10.003_bb0250","first-page":"3","article-title":"The regulatory effects of cytokines on lymphatic angiogenesis","volume":"30","author":"Liu","year":"1997","journal-title":"Lymphology"},{"issue":"7","key":"10.1016\/j.lfs.2015.10.003_bb0255","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00104-002-0453-1","article-title":"Leflunomide reduces the angiogenesis score and tumor growth of subcutaneously implanted colon carcinoma cells in the mouse model","volume":"73","author":"Mall","year":"2002","journal-title":"Der Chirurg; Z. fur alle Gebiete der operativen Medizen"},{"key":"10.1016\/j.lfs.2015.10.003_bb0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-5793(93)81704-4","article-title":"Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide","volume":"334","author":"Mattar","year":"1993","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08977190701773070","article-title":"HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways","volume":"25","author":"Mehta","year":"2007","journal-title":"Growth Factors"},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/molehr\/7.1.65","article-title":"Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle","volume":"7","author":"M\u00f6ller","year":"2001","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.lfs.2015.10.003_bb0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejphar.2013.11.022","article-title":"Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice","volume":"723","author":"Nasr","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0285","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","article-title":"A mutant epidermal growth factor common in human glioma confers enhanced tumorigenicity","volume":"91","author":"Nishikawa","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2015.10.003_bb0290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2741\/A635","article-title":"The role of EGF-related peptides in tumor growth","volume":"6","author":"Normanno","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2015.10.003_bb0295","doi-asserted-by":"crossref","unstructured":"O'Donnell, E.F., Kopparapu, P.R., Koch, D.C., Jang, H.S., Phillips, J.L., Tanguay, R.L., Kerkvliet, N.I., Kolluri, S.K., 2012. The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells. PLoS One 7(7):e40926.","DOI":"10.1371\/journal.pone.0040926"},{"key":"10.1016\/j.lfs.2015.10.003_bb0300","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","article-title":"Vascular endothelial growth factor B, a novel growth factor for endothelial cells","volume":"93","author":"Olofsson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2015.10.003_bb0305","unstructured":"Palmer, A.M., 2010. Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis. Curr. Opin. Investig. Drugs 11(11), 1313\u20131323."},{"key":"10.1016\/j.lfs.2015.10.003_bb0310","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5858\/2000-124-1061-IEOVEG","article-title":"Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistage hepatocarcinogenesis","volume":"124","author":"Park","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1734-1140(09)70033-7","article-title":"IL-1beta, IL-6, and TNF gene polymorphisms do not affect the treatment outcome of rheumatoid arthritis patients with leflunomide","volume":"61","author":"Pawlik","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0325","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1081\/IPH-200042289","article-title":"Ehrlich ascites tumor as a tool in the development of compounds with immunomodulatory properties","volume":"26","author":"Queiroz","year":"2004","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0330","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.leu.2404922","article-title":"The immunomodulatory drug leflunomide inhibits cell cycle progression of B-CLL cells","volume":"22","author":"Ringshausen","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.10305","article-title":"Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis","volume":"84","author":"Rutkowski","year":"2003","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0340","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0345","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cbi.2013.09.004","article-title":"Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor","volume":"206","author":"Saraswati","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.lfs.2015.10.003_bb0350","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymeth.2007.09.006","article-title":"Real-time PCR quantification of precursor and mature microRNA","volume":"44","author":"Schmittgen","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2015.10.003_bb0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00157687","article-title":"EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism","volume":"14","author":"Segall","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.lfs.2015.10.003_bb0360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jcp.21635","article-title":"The epidermal growth factor receptor ligands at a glance","volume":"218","author":"Schneider","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2015.10.003_bb0365","first-page":"1","article-title":"Metastatic cells can escape the proapoptotic effects of TNF-although increased autocrine IL-6\/STAT3 signaling","volume":"72","author":"Shun","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0370","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/1097-0142(19930601)71:11<3552::AID-CNCR2820711115>3.0.CO;2-N","article-title":"Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score","volume":"71","author":"Tahan","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2015.10.003_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00015","article-title":"Is angiogenesis a hallmark of prostate cancer?","volume":"3","author":"Taverna","year":"2013","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2015.10.003_bb0380","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/imt.10.52","article-title":"Leflunomide: a drug with a potential beyond rheumatology","volume":"2","author":"Teschner","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.lfs.2015.10.003_bb0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01742530","article-title":"Epidermal growth factor receptor expression in human gliomas","volume":"33","author":"Torp","year":"1991","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0390","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4149\/neo_2014_026","article-title":"Coexpression of IL-6 and TNF-\u03b1: prognostic significance on breast cancer outcome","volume":"61","author":"Tripsianis","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.lfs.2015.10.003_bb0395","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1349-7006.1996.tb00202.x","article-title":"Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator\/inhibitor, and tubular morphogenesis in human microvascular endothelial cells","volume":"87","author":"Ushiro","year":"1996","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.lfs.2015.10.003_bb0400","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/ard.2004.025205","article-title":"Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis","volume":"64","author":"Van-Roon","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2015.10.003_bb0405","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/00007890-200111150-00018","article-title":"Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide","volume":"72","author":"Waldman","year":"2001","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.lfs.2015.10.003_bb0410","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0006-2952(99)00228-2","article-title":"In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action","volume":"58","author":"Xu","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2015.10.003_bb0415","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3748\/wjg.v9.i2.320","article-title":"Effect of leflunomide on immunological liver injury in mice","volume":"9","author":"Yao","year":"2003","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.lfs.2015.10.003_bb0420","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11596-008-0332-1","article-title":"The active metabolite of leflunomide A771726 inhibits corneal neovascularization","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.lfs.2015.10.003_bb0425","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1006314501634","article-title":"Inhibition of tumor growth and metastasis by targeting tumor associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor","volume":"17","author":"Zhu","year":"1999","journal-title":"Investig. New Drugs"},{"issue":"18","key":"10.1016\/j.lfs.2015.10.003_bb0430","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3748\/wjg.v17.i18.2315","article-title":"Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer","volume":"17","author":"Zhu","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2015.10.003_bb0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14712598.1.2.253","article-title":"General aspects of anti-angiogenesis and cancer therapy","volume":"1","author":"Zogakis","year":"2001","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.lfs.2015.10.003_bb0440","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830260406","article-title":"CD31IPECAM-l driven chemokine-independent transmigration of human T-lymphocytes","volume":"26","author":"Zocchi","year":"1996","journal-title":"Eur. J. Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T03:17:46Z","timestamp":1653275866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":88,"alternative-id":["S0024320515300291"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.10.003","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemopreventive effect of leflunomide against Ehrlich's solid tumor grown in mice: Effect on EGF and EGFR expression and tumor proliferation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}